Naoki Okada

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 7

Top Topics

Dendritic Cells

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Sachiko Hirobe, Seina Nagai, Masashi Tachibana, Naoki Okada
Binding and Efficacy of Anti-Robo4 CAR-T Cells against Solid Tumors. Biomedicines 10 (6) (2022)
Sachiko Hirobe, Taki Yamasaki, Sayami Ito, Ying-Shu Quan, Fumio Kamiyama, Masashi Tachibana, Naoki Okada
Transcutaneous Administration of Imiquimod Promotes T and B Cell Differentiation into Effector Cells or Plasma Cells. Pharmaceutics 14 (2) (2022)
Sachiko Hirobe, Keisuke Imaeda, Masashi Tachibana, Naoki Okada
The Effects of Chimeric Antigen Receptor (CAR) Hinge Domain Post-Translational Modifications on CAR-T Cell Activity. International journal of molecular sciences 23 (7) (2022)
Kento Fujiwara, Masaki Kitaura, Ayaka Tsunei, Hotaka Kusabuka, Erika Ogaki, Naoki Okada
Structure of the Signal Transduction Domain in Second-Generation CAR Regulates the Input Efficiency of CAR Signals. International journal of molecular sciences 22 (5) (2021)
Sachiko Hirobe, Takuto Kawakita, Taki Yamasaki, Sayami Ito, Masashi Tachibana, Naoki Okada
Adjuvant Activity of CpG-Oligonucleotide Administered Transcutaneously in Combination with Vaccination Using a Self-Dissolving Microneedle Patch in Mice. Vaccines 9 (12) (2021)
Kento Fujiwara, Kazuki Shigematsu, Masashi Tachibana, Naoki Okada
Development and functional analysis of an anticancer T-cell medicine with immune checkpoint inhibitory ability. IUBMB life 72 (8) (2020)
Kento Fujiwara, Shigemi Sasawatari, Sho Nakai, Keisuke Imaeda, Seina Nagai, Yoshihiro Matsuno, Kanako Hatanaka, Yutaka Hatanaka, Satoshi Takenaka, Naoki Okada
Predicting the Efficacy and Safety of TACTICs (Tumor Angiogenesis-Specific CAR-T Cells Impacting Cancers) Therapy for Soft Tissue Sarcoma Patients. Cancers 12 (10) (2020)